These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7870892)

  • 1. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?
    File SE; Zangrossi H
    Psychopharmacology (Berl); 1993; 110(1-2):240-4. PubMed ID: 7870892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze.
    File SE; Mabbutt PS; Hitchcott PK
    Psychopharmacology (Berl); 1990; 102(1):98-101. PubMed ID: 1975449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure.
    Frussa-Filho R; Ribeiro Rde A
    Life Sci; 2002 Jun; 71(5):519-25. PubMed ID: 12052436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze test is abolished by previous administration of chlordiazepoxide or buspirone.
    Escarabajal MD; Torres C; Flaherty CF
    Life Sci; 2003 Jul; 73(8):1063-74. PubMed ID: 12818358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze.
    Holmes A; Rodgers RJ
    Neurosci Biobehav Rev; 1999 Nov; 23(7):971-80. PubMed ID: 10580311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of a plus-maze to measure anxiety in the mouse.
    Lister RG
    Psychopharmacology (Berl); 1987; 92(2):180-5. PubMed ID: 3110839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlordiazepoxide reduces the generalised anxiety, but not the direct responses, of rats exposed to cat odor.
    Zangrossi H; File SE
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1195-200. PubMed ID: 1475304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs.
    Evenden J; Ross L; Jonak G; Zhou J
    Behav Pharmacol; 2009 May; 20(3):226-36. PubMed ID: 19455771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay of learning and anxiety in the elevated plus-maze.
    File SE
    Behav Brain Res; 1993 Dec; 58(1-2):199-202. PubMed ID: 8136046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial 2 in the elevated plus-maze: a different form of fear?
    File SE; Zangrossi H; Viana M; Graeff FG
    Psychopharmacology (Berl); 1993; 111(4):491-4. PubMed ID: 7870992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation.
    Pereira JK; Vieira RJ; Konishi CT; Ribeiro RA; Frussa-Filho R
    Life Sci; 1999; 65(10):PL101-7. PubMed ID: 10499876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure.
    Dawson GR; Crawford SP; Stanhope KJ; Iversen SD; Tricklebank MD
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):570-2. PubMed ID: 7862878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fear-potentiation in the elevated plus-maze test depends on stressor controllability and fear conditioning.
    Korte SM; De Boer SF; Bohus B
    Stress; 1999 Aug; 3(1):27-40. PubMed ID: 19016191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S; File SE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
    Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of open arm ledges and maze experience in the elevated plus-maze.
    Fernandes C; File SE
    Pharmacol Biochem Behav; 1996 May; 54(1):31-40. PubMed ID: 8728536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An animal model for measuring behavioral responses to anxiogenic and anxiolytic manipulations.
    Stout JC; Weiss JM
    Pharmacol Biochem Behav; 1994 Mar; 47(3):459-65. PubMed ID: 7911574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of repeated-trial tolerance to the anxiolytic-like effects of chlordiazepoxide in the rat triple test.
    Wehrmeister TD; Izídio GS; Pereira E; Izídio G; Ramos A
    Pharmacol Biochem Behav; 2010 Dec; 97(2):301-9. PubMed ID: 20817009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety.
    File SE; Gonzalez LE; Gallant R
    Neuropsychopharmacology; 1999 Aug; 21(2):312-20. PubMed ID: 10432479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
    Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
    Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.